assurance maladie maternité – Remboursement du traitement du syndrome d'Ehlers-Danlos

This written question concerns the reimbursement of treatments for Ehlers-Danlos Syndrome under the French health insurance system. It seeks clarification on the coverage and accessibility of necessary medical care for individuals affected by this rare genetic disorder. The question addresses patients suffering from Ehlers-Danlos Syndrome and healthcare providers involved in their treatment. It aims to ensure adequate financial support and access to specialized care for affected individuals within the national health framework.